SCHEMBL5224591

SCHEMBL5224591

CC(=CCC(C)NC(=O)OC(C)(C)C)c1cnc2[nH]ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 8/20 0.39
CDK7 P50613 2/20 0.39
KDR P35968 2/20 0.39
PLK4 O00444 1/20 0.39
DCLK1 O15075 1/20 0.39
ROCK2 O75116 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
PAK4 O96013 1/20 0.39
CHEK2 O96017 1/20 0.39
INSR P06213 1/20 0.39
CDK1 P06493 1/20 0.39
FES P07332 1/20 0.39
ROS1 P08922 1/20 0.39
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
FER P16591 1/20 0.39
CDK2 P24941 1/20 0.39
MARK3 P27448 1/20 0.39
LTK P29376 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5197286 0.84 CA1 (0.35) TRPA1AAK1CA1CA2CA4
SCHEMBL6451903 0.78 NNMT (0.41) MKNK2TRPA1AAK1CA1CA2
SCHEMBL5197178 0.77 CYP1A2 (0.41) AAK1
SCHEMBL6462042 0.76 ACACB (0.35) TRPA1AAK1CA1CA2CA4
SCHEMBL3910420 0.75 CHRNB2 (0.38) TRPA1AAK1CA1CA2CA4
SCHEMBL28188182 0.75 CDK8 (0.52) CDK8CDK7KDRPLK4DCLK1
SCHEMBL5224582 0.73 CDK8 (0.36) CDK8CDK7KDRPLK4DCLK1
SCHEMBL3346697 0.70 ABL1 (0.50) KDRMAP4K4CHEK2CDK1FES
SCHEMBL27033549 0.69 KDR (0.50) CDK8CDK7KDRPLK4DCLK1
SCHEMBL7529061 0.69 CA2 (0.40) JAK3CA1CA2CA4CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814852-A2 HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS Targacept, Inc. (US) 2007-08-08 EP disclosed
WO-2006053082-A2 HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS TARGACEPT, INC. (US) 2006-05-18 WO disclosed
EP-1317267-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE Targacept, Inc. (US) 2003-06-11 EP disclosed
EP-1311265-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS Targacept, Inc. (US) 2003-05-21 EP disclosed
EP-1185514-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE Targacept, Inc. (US) 2002-03-13 EP disclosed
WO-2002005801-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE TARGACEPT, INC. (US) 2002-01-24 WO disclosed
WO-2002005798-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS TARGACEPT, INC. (US) 2002-01-24 WO disclosed
WO-2000075110-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE TARGACEPT, INC. (US) 2000-12-14 WO disclosed